Filing Flows › BioAge Labs (BIOA) › Q3 2026 › vs Q2 2026
BioAge Labs (BIOA) Q3 2026 vs Q2 2026 (quarter over quarter)
BioAge Labs's revenue fell $2.2M (-88%) from $2.5M in Q2 2026 to $298K in Q3 2026.
BioAge Labs, Q3 2026: revenue $298K (-86% year over year), net loss $33.5M, operating cash flow −$31.0M. The chart draws each line against Q2 2026, the increases inside each band.
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $298K | $2.5M | −$2.2M | -88% |
| Other income, net | $3.9M | $3.2M | $671K | +21% |
| Net loss | $33.5M | $26.1M | $7.4M | +28% |
| Costs & expenses | $37.7M | $31.8M | $5.9M | +19% |
| Operating costs | $37.7M | $31.8M | $5.9M | +19% |
| Research & development | $30.2M | $24.4M | $5.9M | +24% |
| General & admin | $7.5M | $7.4M | $57K | +0.8% |
| Operating cash sources | $35.7M | $23.5M | $12.2M | +52% |
| Depreciation | $100K | $0 | $100K | — |
| Share-based compensation | $4.6M | $4.3M | $375K | +9% |
| Cash used in operations | $31.0M | $19.3M | $11.7M | +61% |
| Net loss absorbed | $33.5M | $26.1M | $7.4M | +28% |
| Working capital & other | $2.2M | −$2.6M | $4.8M | — |
Questions
How much did BioAge Labs's revenue grow quarter over quarter in Q3 2026?
BioAge Labs's revenue fell $2.2M (-88%) from $2.5M in Q2 2026 to $298K in Q3 2026.